Oscotec Inc. (KOSDAQ:039200)
South Korea · Delayed Price · Currency is KRW 34,800
-250 (-0.71%)
Sep 9, 2026, 3:30 PM KST
Oscotec Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 144,182 | 99,839 | 34,008 | 4,951 | 5,062 | 3,903 |
Revenue Growth | 232.64% | 193.58% | 586.89% | -2.20% | 29.71% | -91.02% |
Gross Profit Gross Profit Growth | 141,917 | 97,687 | 31,436 | 2,747 | 2,839 | 1,768 |
Operating Income Operating Income Growth | 89,718 | 52,081 | -2,734 | -32,655 | -28,638 | -28,097 |
Net Income Net Income Growth | 94,062 | 52,343 | 876.53 | -24,280 | -24,430 | -26,263 |
Earnings Per Share EPS Growth | 2458.32 | 1368.00 | 22.92 | -635.00 | -763.19 | -866.00 |
EPS Growth | 2110.26% | 5868.90% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Business Sector Medical Business Sector Growth | 1,775 | 1,778 | 2,275 | 2,617 | 2,737 | 2,735 |
Functional Materials Functional Materials Growth | 213.8 | 283.37 | 398.2 | 295.24 | 401 | - |
Food Business Food Business Growth | 1,312 | 1,101 | 1,074 | 751.48 | 801.64 | 699.53 |
New Drug Business Division New Drug Business Division Growth | 140,882 | 96,676 | 30,260 | 1,287 | 1,123 | - |
Total Total Growth | 144,182 | 99,839 | 34,008 | 4,951 | 5,062 | 3,903 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 210,667 | 108,087 | 102,728 | 97,481 | 103,696 | 14,584 |
Total Debt Total Debt Growth | 17,809 | 15,618 | 13,816 | 24,612 | 10,085 | 7,252 |
Net Cash (Debt) Net Cash Growth | 192,859 | 92,469 | 88,912 | 72,868 | 93,611 | 7,333 |
Net Cash Growth | 90.27% | 4.00% | 22.02% | -22.16% | 1176.64% | -72.23% |
Net Cash Per Share Net Cash Per Share Growth | 5041.13 | 2417.37 | 2324.81 | 1905.34 | 2924.46 | 241.76 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 90,537 | 8,302 | -26,034 | -22,048 | -26,421 | -8,762 |
Capital Expenditures CapEx Growth | -952.75 | -779.65 | -623.78 | -581.22 | -1,249 | -7,518 |
Free Cash Flow Free Cash Flow Growth | 89,585 | 7,523 | -26,657 | -22,629 | -27,670 | -16,280 |
Free Cash Flow Growth | 15650.02% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 98.43% | 97.84% | 92.44% | 55.49% | 56.08% | 45.30% |
Operating Margin | 62.22% | 52.16% | -8.04% | -659.58% | -565.71% | -719.93% |
Pretax Margin | 68.51% | 52.87% | -3.29% | -652.07% | -552.76% | -732.38% |
Profit Margin | 65.24% | 52.43% | 2.58% | -490.40% | -482.57% | -672.93% |
FCF Margin | 62.13% | 7.54% | -78.39% | -457.06% | -546.58% | -417.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.16 | 33.04 | 1067.90 | - | - | - |
Forward PE | 41.38 | 48.46 | 73.96 | 69.40 | 69.40 | 69.40 |
P/FCF Ratio | 14.86 | 229.87 | - | - | - | - |
PS Ratio | 9.23 | 17.32 | 27.52 | 177.78 | 129.49 | 284.45 |